Literature DB >> 22504589

Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice.

Yong Zhang1, Stefan D Schlussman, Eduardo R Butelman, Ann Ho, Mary Jeanne Kreek.   

Abstract

UNLABELLED: Relapse is a serious problem for the effective treatment of cocaine addiction. RATIONALE: Examining cocaine re-exposure-induced behavioral and neurobiological alterations following chronic escalating-dose binge cocaine administration and withdrawal may provide insight into the neurobiological basis of cocaine relapse.
OBJECTIVES: Our goal was to determine how exposure to chronic escalating-dose cocaine affects development of subsequent cocaine-induced conditioned place preference (CPP) and changes in endogenous opioid systems.
METHODS: Mice were injected with either escalating-dose binge cocaine (15-30 mg/kg/injection × 3/day) or saline for 14-days and conditioned with 15 mg/kg of cocaine or saline (once per day for 10-days), starting either 1 or 14-days after the last day of binge injections.
RESULTS: Mice exposed to chronic escalating cocaine did not develop CPP to cocaine when conditioning commenced on the first day of withdrawal (CPP test on day 10 of withdrawal). By contrast, mice did develop CPP to cocaine when conditioning started on the 14th day of withdrawal (CPP test on day 24 of withdrawal). Furthermore, preproenkephalin (Penk) mRNA levels in caudate putamen were significantly higher in mice that received 14-day withdrawal from escalating-dose binge cocaine before the CPP procedure (tested 24 days post-binge) than those that received 1-day withdrawal (tested 10 days post-binge).
CONCLUSIONS: The rewarding effect of cocaine was blunted in early withdrawal from chronic escalating exposure, but recovered in more prolonged withdrawal. Time-dependent elevations in Penk mRNA levels may be part of the underlying mechanisms of this effect.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504589      PMCID: PMC3979702          DOI: 10.1016/j.neuropharm.2012.03.021

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  44 in total

1.  Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.

Authors:  Ty A Ridenour; Mildred Maldonado-Molina; Wilson M Compton; Edward L Spitznagel; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2005-04-26       Impact factor: 4.492

2.  Transition from moderate to excessive drug intake: change in hedonic set point.

Authors:  S H Ahmed; G F Koob
Journal:  Science       Date:  1998-10-09       Impact factor: 47.728

3.  Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute "binge" cocaine.

Authors:  R Spangler; Y Zhou; C E Maggos; S D Schlussman; A Ho; M J Kreek
Journal:  Brain Res Mol Brain Res       Date:  1997-02

4.  Long-term cocaine self-administration decreases striatal preproenkephalin mRNA in rhesus monkeys.

Authors:  J B Daunais; M A Nader; L J Porrino
Journal:  Pharmacol Biochem Behav       Date:  1997-07       Impact factor: 3.533

5.  Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence.

Authors:  P Svensson; Y L Hurd
Journal:  Brain Res Mol Brain Res       Date:  1998-05

6.  Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal.

Authors:  L T Tran-Nguyen; R A Fuchs; G P Coffey; D A Baker; L E O'Dell; J L Neisewander
Journal:  Neuropsychopharmacology       Date:  1998-07       Impact factor: 7.853

7.  The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.

Authors:  J Turchan; B Przewłocka; G Toth; W Lasoń; A Borsodi; R Przewłocki
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

8.  Steady-dose and escalating-dose "binge" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats.

Authors:  Stefan D Schlussman; Yan Zhou; Alexis Bailey; Ann Ho; Mary Jeanne Kreek
Journal:  Brain Res Bull       Date:  2005-10-15       Impact factor: 4.077

9.  Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat.

Authors:  A M Mathieu-Kia; M J Besson
Journal:  Brain Res Mol Brain Res       Date:  1998-02

10.  Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

Authors:  A Alt; A Mansour; H Akil; F Medzihradsky; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  4 in total

Review 1.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

2.  Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice.

Authors:  Keiichi Niikura; Ann Ho; Mary Jeanne Kreek; Yong Zhang
Journal:  Pharmacol Biochem Behav       Date:  2013-07-01       Impact factor: 3.533

Review 3.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

Review 4.  Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction.

Authors:  Bethania Mongi-Bragato; María P Avalos; Andrea S Guzmán; Flavia A Bollati; Liliana M Cancela
Journal:  Front Psychiatry       Date:  2018-05-28       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.